The Phase III Adaptive Radiation and Chemotherapy for Muscle Invasive Bladder Cancer Trial (ARCHER)

Disease Sites:

Bladder

Staging:

Phase III

Age Group:

Adults

Therapies:

Chemotherapy - cytotoxic, Radiotherapy

Drugs:

Cisplatin, Fluorouracil (5-FU), Gemcitabine, Mitomycin-C

Principal Investigator(s):

Kirschner, Austin

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

12-23-2025

Trial Type:

Treatment

Protocol ID:

NRGUROGU015

National Clinical Trial ID:

NCT07097142

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available